- DE EN
- About Us
- Study Participation
Exchange and collaboration with national and international colleagues are very important for our internationally oriented institute. Therefore we collaborate with many different international partners to advance research in the area of diabetes technology.
The DCB is an independent, private foundation in Switzerland that supports research projects and startups all over the world in the area of diabetes technology.
The DCB and the IfDT have a collaboration agreement and conduct projects regarding diabetes technology together. Main focus of that work is to make life easier for people with diabetes.
FIND is an independent, non-governmental, non-profit organization who aims to improve the supply of people in low-income countries with medical devices for diagnosis of infectious and chronic diseases. Together with the IfDT, the field of activity in diabetes mellitus shall be expanded to include product evaluations of blood glucose measurements.
At the faculty for mechatronic and medical engineering of the THU the „LoopInsighT1“-simulator was developed under the lead of Prof. Dr. Heiko Peuscher. Aim of our cooperation with the THU is the further development and the expansion of applications for the simulator, e.g. for educational purposes and the support of student theses.
At the end of 2019, the working group “Continuous glucose monitoring” (WG-CGM) of the Scientific Division of the IFCC was founded. Dr. Freckmann is chair of this working group who aims to develop international standards for CGM. The IfDT supports the working group through research, data evaluation, content preparation for different questions and the writing of publications.
Dr. Freckmann is chairman of the Arbeitsgemeinschaft Diabetes & Technologie der DDG and is also supported by the scientific colleagues in his activities, e.g. in the preparation of publications. In addition, the office of the AGDT is located in our house.
To improve the reader-friendliness of our website, we use the generic masculine. In the context of equal treatment, we would like to point out that the content of our website is aimed at all genders and does not contain any valuation.